Literature DB >> 21721867

Symptomatic Rathke cleft cysts: extent of resection and surgical complications.

Dominique M Higgins1, Jamie J Van Gompel, Todd B Nippoldt, Fredric B Meyer.   

Abstract

OBJECT: Rathke cleft cysts (RCCs) are benign masses arising from the embryological Rathke pouch, and are commonly treated by transsphenoidal surgery. The authors retrospectively compared RCC extent of resection-either gross-total resection (GTR) or decompression-to the primary outcome measure, which was recurrences resulting in repeat surgery, and the secondary outcome measure, which was complications.
METHODS: Seventy-four patients presenting to the neurosurgical department with RCC were analyzed retrospectively. Sixty-eight patients had a total of 78 surgical procedures, with the diagnosis of RCC confirmed by histological investigation; of these, 61 patients had adequate operative notes for the authors to evaluate extent of resection. Groups were separated into GTR (32 patients) or decompression (subtotal resection or fenestration into the sphenoid sinus; 29 patients) based on operative notes and postoperative imaging. The mean follow-up duration was 60.5 ± 72.1 months (the mean is expressed ± SD throughout).
RESULTS: The average age at the time of the initial surgery was 42.8 ± 17.4 years, and 70% of patients were female. The mean cyst diameter preoperatively was 16.9 ± 17.8 mm. Eight patients had repeat surgery, our primary outcome measure; 3 repeat operations occurred in the GTR group, and 5 in the decompression group. There was no significant difference in recurrence when comparing groups (GTR 9%, decompression 17%; p = 0.36). There were no major complications; however, analysis of postoperative minor complications revealed that 11 (34%) GTRs resulted in surgical complications, whereas the decompression cohort accounted for only 3 complications (10%) (p = 0.03), with diabetes insipidus (6) and CSF leaks (5) being the most common. Gross-total resection also resulted in an increase in postoperative hyperprolactinemia compared with decompression (p = 0.03).
CONCLUSIONS: It appears that RCCs require repeat surgery in 13% of cases, and attempted GTR does not appear to reduce the overall rate of recurrence. However, more aggressive resections are associated with more complications in this series.

Entities:  

Mesh:

Year:  2011        PMID: 21721867     DOI: 10.3171/2011.5.FOCUS1175

Source DB:  PubMed          Journal:  Neurosurg Focus        ISSN: 1092-0684            Impact factor:   4.047


  10 in total

1.  Treatment Outcomes of Rathke's Cleft Cysts Managed with Marsupialization.

Authors:  Edward C Kuan; Frederick Yoo; Jennifer Chyu; Marvin Bergsneider; Marilene B Wang
Journal:  J Neurol Surg B Skull Base       Date:  2016-08-16

2.  Surgical outcomes and quality of life in Rathke's cleft cysts undergoing endoscopic transsphenoidal resection: a multicentre study and systematic review of the literature.

Authors:  Mendel Castle-Kirszbaum; Jeremy Kam; Yi Yuen Wang; James King; Kylie Fryer; Tony Goldschlager
Journal:  Pituitary       Date:  2022-01-10       Impact factor: 4.107

3.  Professor Rathke's gift to neurosurgery: the cyst, its diagnosis, surgical management, and outcomes.

Authors:  Alaa S Montaser; Michael P Catalino; Edward R Laws
Journal:  Pituitary       Date:  2021-05-27       Impact factor: 4.107

4.  Rathke's cleft cysts following transsphenoidal surgery: long-term outcomes and development of an optimal follow-up strategy.

Authors:  Hani J Marcus; Anouk Borg; Ziad Hussein; Zane Jaunmuktane; Stephanie E Baldeweg; Joan Grieve; Neil L Dorward
Journal:  Acta Neurochir (Wien)       Date:  2020-01-25       Impact factor: 2.216

5.  Spinal dural arteriovenous fistula rupture after Rathke's cleft cyst endoscopic resection: Case report and literature review.

Authors:  Jefferson Trivino-Sanchez; Pedro Henrique Costa Ferreira-Pinto; Elington Lannes Simões; Felipe Gonçalves Carvalho; Diego Rodrigues Menezes; Thaina Zanon Cruz; Julia Pereira Muniz Pontes; Ana Beatriz Winter Tavares; Flavio Nigri
Journal:  Surg Neurol Int       Date:  2021-09-06

6.  Nonabsorbable intrasellar stent placement for recurrent Rathke cleft cyst: illustrative case.

Authors:  Nathaniel R Ellens; Matthew C Miller; Ismat Shafiq; Zoe R Williams; G Edward Vates
Journal:  J Neurosurg Case Lessons       Date:  2021-04-12

7.  Conservative management of complicated Rathke's cleft cyst mimicking pituitary apoplexy.

Authors:  S M Constantinescu; G Wilms; R M Furnica; T Duprez; D Maiter
Journal:  Endocrinol Diabetes Metab Case Rep       Date:  2022-08-01

8.  Rathke's cleft cysts: A single-center case series.

Authors:  Guive Sharifi; Arsalan Amin; Mahmoud Lotfinia; Mohammad Hallajnejad; Zahra Davoudi; Nader Akbari Dilmaghani; Omidvar Rezaei Mirghaed
Journal:  Surg Neurol Int       Date:  2022-08-19

9.  Predictive factors for delayed hyponatremia after transsphenoidal surgery in patients with Rathke's cleft cysts.

Authors:  Kunzhe Lin; Zhijie Pei; Yibin Zhang; Tianshun Feng; Shousen Wang
Journal:  Front Oncol       Date:  2022-09-13       Impact factor: 5.738

10.  Reverse Trans-Sellar Neuroendoscopic Management of a Large Rathke's Cleft Cyst Causing Obstructive Hydrocephalus: A Case Report.

Authors:  Han-Joo Lee; Hyon-Jo Kwon; Seung-Won Choi; Seon-Hwan Kim; Hyeon-Song Koh; Jin-Young Youm; Kyung Hwan Kim
Journal:  Brain Tumor Res Treat       Date:  2022-01
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.